Dosing strategies for conversion of haemodialysis patients from short-acting erythropoiesis stimulating agents to once-monthly C.E.R.A.: experience from the MIRACEL study von Dellanna, F., Winkler, R. E., Bozkurt, F., Schettler, V., Graf, S., Bockreiss, N., Fliser, D.

Volltext

TAGS: A phase III, randomised, double-blind study of trifluridine/tipiracil (TAS-102) versus placebo in patients with refractory metastatic gastric cancer von Arkenau, H.-T., Tabernero, J., Shitara, K., Dvorkin, M., Mansoor, W., Prokharau, A., Alsina, M., Ghidini, M., Faustino, C., Gorbunova, V., Zhavrid, E.A., Nishikawa, K., Hosokawa, A., Ganea, D., Yalçın, Ş, Beretta, G.D., Winkler, R.E., Makris, L., Doi, T., Ilson, D.H.

Volltext

Selective apheresis--time for a change von Matic, G, Winkler, R E, Tiess, M, Ramlow, W

Volltext

The outcome in myasthenia gravis patients – an eight-year follow-up after finishing immunoabsorption therapy von Schneidewind, J.M, Zettl, U.K, Winkler, R.E, Ramlow, W, Tiess, M, Michelsen, A, Hebestreit, G, Prophet, H, Pätow, W, Benecke, R

Volltext

LBA25TAGS: A phase III, randomised, double-blind study of trifluridine/tipiracil (TAS-102) versus placebo in patients with refractory metastatic gastric cancer von Arkenau, H-T, Tabernero, J, Shitara, K, Dvorkin, M, Mansoor, W, Prokharau, A, Alsina, M, Ghidini, M, Faustino, C, Gorbunova, V, Zhavrid, E A, Nishikawa, K, Hosokawa, A, Ganea, D, Yalçın, Ş, Beretta, G D, Winkler, R E, Makris, L, Doi, T, Ilson, D H

Volltext

Impact of prior chemotherapy on progression-free survival in patients (pts) with advanced pancreatic neuroendocrine tumors (pNET): Results from the RADIANT-3 trial von Pommier, R. F., Wolin, E. M., Panneerselvam, A., Saletan, S., Winkler, R. E., Van Cutsem, E.

Volltext

Everolimus in patients with advanced pancreatic neuroendocrine tumors (pNET): Updated results of a randomized, double-blind, placebo-controlled, multicenter, phase III trial (RADIA... von Strosberg, J. R., Lincy, J., Winkler, R. E., Wolin, E. M.

Volltext

Everolimus plus octreotide LAR versus placebo plus octreotide LAR in patients with advanced neuroendocrine tumors: Analysis by primary tumor site from RADIANT-2 von Wolin, E. M., Fazio, N., Saletan, S., Winkler, R. E., Panneerselvam, A., Kvols, L.

Volltext

Everolimus plus octreotide LAR versus placebo plus octreotide LAR in patients with advanced neuroendocrine tumors (NET): Updated safety and efficacy results from RADIANT-2 von Yao, J. C., Ricci, S., Winkler, R. E., Jehl, V., Pavel, M. E.

Volltext

Using a novel microstructure generator to calculate macroscopic properties of multi-phase non-oxide ceramics in comparison to experiments von Winkler, D.E.R., Staab, T.E.M., Müller, T.M., Raether, F.G.

Volltext

Everolimus in patients with advanced pancreatic neuroendocrine tumors (pNET): Impact of somatostatin analog use on progression-free survival in the RADIANT-3 trial von Shah, M. H., Lombard-Bohas, C., Ito, T., Wolin, E. M., Van Cutsem, E., Sachs, C., Winkler, R. E., Lincy, J., Hobday, T. J., Yao, J. C.

Volltext

Effect of everolimus treatment on chromogranin A, neuron-specific enolase, gastrin, and glucagon levels in patients with advanced pancreatic neuroendocrine tumors (pNET): Phase III... von De Vries, E., Anthony, L. B., Sideris, L., Chen, L., Lebrec, J., Tsuchihashi, Z., Winkler, R. E., Yao, J. C., Oberg, K. E.

Volltext

Everolimus in patients with advanced pancreatic neuroendocrine tumors (pNET): Updated results of a randomized, double-blind, placebo-controlled, multicenter phase III trial (RADIAN... von Shah, M. H., Ito, T., Lombard-Bohas, C., Wolin, E. M., Van Cutsem, E., Sachs, C., Winkler, R. E., Lincy, J., Hobday, T. J., Yao, J. C.

Volltext

Reflections on the relevance of the Georgetown paradigm for the ethics of environmental epidemiology von Winkler, Earl R.

Volltext

Phase I study of everolimus in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) von Finn, R. S., Poon, R. T. P., Yau, T., Klumpen, H., Chen, L., Kang, Y., Kim, T., Gomez-Martin, C., Rodriguez-Lope, C., Kunz, T., Paquet, T., Asubonteng, K., Winkler, R. E., Anak, O., Sellami, D. B., Bruix, J.

Volltext

Particle Release in Extracorporeal Low-Density Lipoprotein Lowering Therapies von Martins, Konrad, Ahrenholz, Peter, Matic, Goran B., Hofmann, Doris, Tiess, Michael, Winkler, Roland E., Ramlow, Wolfgang

Volltext

Release of microparticles in LDL apheresis von Matic, Goran B, Martins, Konrad, Ahrenholz, Peter, Tiess, Michael, Winkler, Roland E, Ramlow, Wolfgang

Volltext

Solid Solution of Titanium Dioxide in Aluminum Oxide von WINKLER, E. R., SARVER, J. F., CUTLER, IVAN B.

Volltext

Heats of Hydrogenation. I. Apparatus and the Heats of Hydrogenation of Bicyclo-[2,2,1]heptene, Bicyclo[2,2,1]heptadiene, Bicyclo[2,2,2]octene and Bicyclo[2,2,2]octadiene von Turner, Richard B, Meador, W. R, Winkler, R. E

Volltext

Aircrew helmet design and manufacturing enhancements through the use of advanced technologies von Cadogan, David P., George, Alan E., Winkler, Edward R.

Volltext